Home › Myoclonic Epilepsies › California
Myoclonic Epilepsies clinical trials in California
3 studies for Myoclonic Epilepsies are looking for participants at sites in California.
A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders
- Scripps Research Translational Institute, San Diego
RecruitingPhase 2
Ages 2 to 60 · All sexes · Updated Sep 29, 2026 · NCT07847918A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- UCSF Benioff Children's Hospitals, San Francisco
RecruitingPhase 1/2
6 Months – 17 Years · All sexes · Updated Sep 22, 2026 · NCT05419492A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- University of California Irvine, Orange
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.